Dr. Maxim Yankelevich, MD
- Publications
- 14
- Clinical trials
- 2
- Hospital affiliations
- 3
- Industry payments
- $1,430
- Medical groups
- 5
- Practice address
- 3601 W Thirteen Mile Rd, Royal Oak, MI 48073
- Practice phone
- Call (248) 898-5400
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. Yankelevich's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Maxim Yankelevich is a pediatric hematology and oncology physician in Royal Oak, Michigan
Dr. Yankelevich practices at Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health.
Dr. Yankelevich's NPI, 1508011776, was assigned on December 1, 2008. Dr. Yankelevich holds Pennsylvania license MD480625.
- NPI
- 1508011776NPI Registry (opens in a new tab)
- Medicare PAC ID
- 4284799800
- NPI enumeration date
- December 1, 2008
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (248) 898-5400
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 60
- Medical school graduation
- 1992
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Maxim Yankelevich practices at Corewell Health William Beaumont University Hospital in Royal Oak, Michigan
Dr. Yankelevich's primary practice is Corewell Health William Beaumont University Hospital, at 3601 W Thirteen Mile Rd, Royal Oak, MI 48073 in Oakland County. The practice phone is (248) 898-5400.
- Corewell Health William Beaumont University Hospital3601 W Thirteen Mile Rd, Royal Oak, MI 48073 · Oakland CountyPhone(248) 898-5400
Source: Dmand AI Affiliation Data
Dr. Maxim Yankelevich is affiliated with 4 sites of care and 5 medical groups
Dr. Yankelevich's primary practice is Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health. Dr. Yankelevich is also affiliated with MUSC Health University Medical Center. The medical group on file is Henry Ford Macomb Hospital. Dmand AI also links Dr. Yankelevich to 1 more hospital, 4 medical groups and 1 group practice or clinic, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Maxim Yankelevich's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yankelevich practices, 4 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Corewell Health William Beaumont University Hospital | Available with a free account |
| +3 more sites and 4 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Corewell Health and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Maxim Yankelevich is one of 86 pediatric hematologys and oncology physicians in Michigan
Pediatric hematology-oncology is Dr. Yankelevich's primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dr. Yankelevich is licensed in Pennsylvania.
Specialties and state licenses
- Pediatric hematology and oncology, PennsylvaniaPrimary
Pediatric hematologys and oncology physicians near Dr. Yankelevich
Counts of pediatric hematologys and oncology physicians with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Maxim Yankelevich's patients have a median age of 13
Across all payers, Dmand AI patient panel data puts Dr. Yankelevich's median patient age at 13, with 45% women.
Dr. Yankelevich's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 13
Patient panel by sex, all payers
- Women45%
- Men55%
Source: Dmand AI Patient Panel Data
How Dr. Maxim Yankelevich takes part in Medicare
Dr. Yankelevich accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
Dr. Maxim Yankelevich has 14 publications on record
Dmand AI links 14 papers to Dr. Yankelevich, published from 2011 to 2024. 2020 was the busiest year, with 3. The most frequent topics are Hematopoietic Stem Cell Transplantation, Carcinoma and Choroid Plexus Neoplasms. Dr. Yankelevich's most frequent co-authors are Roland Lee-Shing Chu, MD, Jonathan Lester Finlay, MD and Basim Isa Asmar, MD.
Dr. Yankelevich's papers by year, 2011 to 2024
Topics Dr. Yankelevich writes about most
- Hematopoietic Stem Cell Transplantation
- Carcinoma
- Choroid Plexus Neoplasms
Dr. Yankelevich's most frequent co-authors
- Roland Lee-Shing Chu, MD5 shared papers
- Jonathan Lester Finlay, MD3 shared papers
- Basim Isa Asmar, MD2 shared papers
Recent publications by Dr. Yankelevich
Cold Spring Harb Mol Case Stud
Pediatr Transplant
See who Dr. Yankelevich researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Yankelevich works with, so you can find a warm path to the right pediatric hematologys and oncology physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Maxim Yankelevich has worked on 2 clinical trials
Dmand AI links Dr. Yankelevich to 2 clinical trials, 2 of them phase 3 studies. 2 are still active or recruiting. Conditions studied include Ependymoma, Neurofibromatosis 1 and Glioma.
Conditions in Dr. Yankelevich's trials
- Ependymoma
- Neurofibromatosis 1
- Glioma
- Neurofibromatoses
Investigators on the most trials with Dr. Yankelevich
- Minnie Abromowitch, MD2 shared trials
- Mark Peter Atlas, MD2 shared trials
- Phillip Evan Barnette2 shared trials
Recent clinical trials with Dr. Yankelevich
A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma (opens in a new tab)
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Maxim Yankelevich received $1,430 in industry payments from 2016 to 2025
CMS Open Payments shows 14 general payments to Dr. Yankelevich from 7 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 50% of the total. Amgen Inc. paid the most, $976.
General payments to Dr. Yankelevich by program year, 2016 to 2025
General payments to Dr. Yankelevich by kind, 2016 to 2025
- Travel and lodging$71650%
- Food and beverage$67447%
- Education$403%
Companies that paid Dr. Yankelevich the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Maxim Yankelevich's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Maxim Yankelevich
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Maxim Yankelevich's NPI number?
Dr. Maxim Yankelevich's NPI number is 1508011776. It was assigned on December 1, 2008, and it is active in the NPI Registry.
What kind of doctor is Dr. Maxim Yankelevich?
Dr. Maxim Yankelevich is a pediatric hematology and oncology physician in Royal Oak, Michigan. The primary specialty in the NPI Registry is Pediatric Hematology & Oncology Physician (taxonomy code 2080P0207X).
Where does Dr. Maxim Yankelevich practice?
Dr. Yankelevich practices at 3601 W Thirteen Mile Rd, Royal Oak, MI 48073. Dr. Yankelevich's primary practice is Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health. Dmand AI also links Dr. Yankelevich to 1 hospital, 4 medical groups and 1 group practice or clinic.
What is Dr. Maxim Yankelevich's office phone number?
The practice phone on file for Dr. Yankelevich is (248) 898-5400.
What is Dr. Maxim Yankelevich's medical license number?
Dr. Yankelevich holds Pennsylvania license MD480625.
Which hospitals is Dr. Maxim Yankelevich affiliated with?
Dr. Yankelevich practices at Corewell Health William Beaumont University Hospital in Royal Oak, Michigan. Dr. Yankelevich is also affiliated with MUSC Health University Medical Center. Dmand AI links Dr. Yankelevich to 1 more hospital.
What medical group is Dr. Maxim Yankelevich part of?
Dr. Yankelevich is linked to Henry Ford Macomb Hospital. Dmand AI links Dr. Yankelevich to 4 more medical groups.
Does Dr. Maxim Yankelevich accept Medicare?
Yes. CMS lists Dr. Yankelevich as accepting Medicare assignment.
Has Dr. Maxim Yankelevich received payments from drug or device companies?
CMS Open Payments shows $1,430 in general payments to Dr. Yankelevich from 7 companies from 2016 to 2025. The largest total came from Amgen Inc.
How long has Dr. Maxim Yankelevich been practicing?
Dr. Yankelevich graduated from medical school in 1992, 34 years ago.
Does Dr. Maxim Yankelevich do research?
Dmand AI links 14 publications to Dr. Yankelevich, published from 2011 to 2024. Dr. Yankelevich has worked on 2 clinical trials.
Who does Dr. Maxim Yankelevich publish with?
Dr. Yankelevich's most frequent co-authors are Roland Lee-Shing Chu, MD (5 shared papers), Jonathan Lester Finlay, MD (3 shared papers) and Basim Isa Asmar, MD (2 shared papers).
Selling to pediatric hematology-oncology practices?
See pediatric hematologys and oncology physicians in Michigan by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card